Rick Pauls
2021
In 2021, Rick Pauls earned a total compensation of $1.1M as President and Chief Executive Officer at DiaMedica Therapeutics, a 29% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $191,590 |
|---|---|
| Option Awards | $452,081 |
| Salary | $477,448 |
| Other | $15,050 |
| Total | $1,136,169 |
Pauls received $477.4K in salary, accounting for 42% of the total pay in 2021.
Pauls also received $191.6K in non-equity incentive plan, $452.1K in option awards and $15.1K in other compensation.
Rankings
In 2021, Rick Pauls' compensation ranked 8,347th out of 12,415 executives tracked by ExecPay. In other words, Pauls earned more than 32.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,347 out of 12,415 | 33rd |
Division Manufacturing | 3,694 out of 5,505 | 33rd |
Major group Chemicals And Allied Products | 1,642 out of 2,375 | 31st |
Industry group Drugs | 1,461 out of 2,096 | 30th |
Industry Pharmaceutical Preparations | 1,088 out of 1,546 | 30th |
Source: SEC filing on April 5, 2022.
Pauls' colleagues
We found two more compensation records of executives who worked with Rick Pauls at DiaMedica Therapeutics in 2021.
News
DiaMedica Therapeutics CEO Rick Pauls' 2023 pay rises 12% to $1.2M
April 4, 2024
DiaMedica Therapeutics CEO Rick Pauls' 2022 pay slips 5% to $1.1M
April 4, 2023
DiaMedica Therapeutics CEO Rick Pauls' 2021 pay jumps 29% to $1.1M
April 5, 2022
DiaMedica Therapeutics CEO Rick Pauls' 2019 pay jumps 105% to $1.5M
April 20, 2020
DiaMedica Therapeutics CEO Rick Pauls' 2018 pay jumps 46% to $734K
April 8, 2019